1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

New Market Report Now Available: Peru Pharmaceuticals & Healthcare Report Q3 2011

New Healthcare research report from Business Monitor International is now available from Fast Market Research

 
PRLog - Jun. 25, 2011 - BMI View: Peru is an attractive emerging pharmaceutical market. However, even though we expect the country to outperform its peers economically, the government seems committed to cost-containment in healthcare and pharmaceuticals. Such measures are seen as necessary to ensure adequate access to medicines through the relatively well-subsidised public sector, given that the government is largely responsible for the procurement of patented products in this area.

Headline Expenditure Projections

* Pharmaceuticals: PEN3.07bn (US$1.09bn) in 2010 to PEN3.22bn (US$1.26bn) in 2011; +5% in local currency terms and +15.5% in US dollar terms. Forecast up slightly from Q211 due to macroeconomic factors.
* Healthcare: PEN20.03bn (US$7.14bn) in 2010 to PEN21.42bn (US$8.40bn) in 2011; +6.9% in local currency terms and +17.6% in US dollar terms. Forecast slightly down from Q211 due to constraints on government contribution to healthcare spending.
* Medical devices: PEN833mn (US$297mn) in 2010 to PEN908mn (US$356mn) in 2011; +9.0% in local currency terms and +19.9% in US dollar terms. Forecast slightly down from Q211 due to constraints on government contribution to healthcare spending.

------------------------------------------------------------
Full Report Details at
- http://www.fastmr.com/prod/171502_peru_pharmaceuticals_he...
------------------------------------------------------------

Business Environment Rating: Peru dropped one place to tenth in our latest regional Business Environment Rating (BER) matrix for the Americas. Its composite score worsened by 6.5% in relation to the previous quarter. Peru's rewards profile is now seen as more problematic, primarily due to modest per-capita spending on drugs, but its risks score is actually not far off the regional average. Globally, Peru ranks 64th out of the total of 83 markets surveyed within our pharmaceuticals universe.

Key Trends & Developments
* Pharmaceutical imports in Peru are likely to increase by 12.5% year-on-year (y-o-y) to US$372.6mn in 2011, reported LivinginPeru.com, citing Peru-based consulting and market research firm Maximixe. The rise in imports can be attributed to improvements in the population's purchase of health insurance. During 2010, as much as 90% of the country's imports included medicine for therapeutic or prophylactic purposes.

BMI Economic View: Collapsing demand for Peruvian assets has also hit the currency hard, with the local tender losing over 2.4% against the US dollar since the middle of March 2011. This will make imported raw materials for the pharmaceutical industry more expensive, thus impacting the bottom line figures of domestic players and their future investment capacities. In the meantime, until we have a clearer picture of the outcome of Peru's presidential elections, we are leaving our core interest rate and inflation (which is largely domestic-led) forecasts unchanged.

BMI Political View: Opinion polls in Peru ahead of the final round of the presidential vote on June 10 2011 indicate that nationalist Ollanta Humala is pulling ahead of Keiko Fujimori. However, with almost a month to go until the ballot and Humala apparently pursuing a more moderate policy platform, we still believe the outcome remains incredibly hard to call. Generally speaking, the possibility of a Humala victory - perceived as being bad for markets and private enterprise due to his anti-investor rhetoric, despite stopping short of nationalisation - continues to weigh on Peruvian assets, including the attractiveness of its pharmaceutical industry to foreign investors. Still, in a further attempt to allay the fears of investors, Humala has made numerous public statements reiterating his commitment to free-trade, foreign investment and private property rights, although signs are unclear if this rhetoric represents a genuine policy shift.

Partial Table of Contents:

SWOT Analysis
- Peru: Pharmaceuticals And Healthcare Industry SWOT
- Peru Political SWOT
- Peru Economic SWOT
- Peru Business Environment SWOT
Pharmaceutical Business Environment Ratings
- Table: Americas - Regional Pharmaceutical Business Environment Ratings, Q311
- Rewards
- Risks
Peru - Market Summary
Regulatory Regime
- Recent Regulatory Developments
- OTC Medicines
- Intellectual Property Regime
- IP       Shortcomings
- Counterfeit Pharmaceuticals
- Trade Agreements
- Pricing Regime
- Government Tenders
- Reimbursement Regime
- Recent Pricing and Reimbursement Developments
Industry Developments
- Epidemiology
- Non-Communicable Diseases
- Communicable Diseases
- Healthcare Sector
- Healthcare Finances
- Healthcare Provision
- Table - Key Goals of Parsalud II in Nine Regions*
- Health Insurance
- Clinical Trials
- Medical Devices
Industry Forecast Scenario
- Overall Market Forecast
- Table: Pharmaceutical Sales Indicators 2007-2015
Key Growth Factors - Industry
- Table: Healthcare Expenditure Indicators 2007-2015
- Table: Government Healthcare Expenditure Indicators 2007-2015
- Table: Private Healthcare Expenditure Indicators 2007-2015
- Key Growth Factors - Macroeconomic
- Table: Peru - Economic Activity
- Prescription Drug Market Forecast
- Table: Prescription Drug Sales Indicators 2007-2015
- Patented Drug Market Forecast
- Table: Patented Drug Market Indicators 2007-2015
- Generic Drug Market Forecast
- Table: Generic Drug Sales Indicators 2007-2015
- OTC Medicine Market Forecast
- Table: OTC Medicine Sales Indicators 2007-2015
- Medical Device Market Forecast
- Table: Medical Devices 2007-2019
- Pharmaceutical Trade Forecast
- Table: Exports and Imports Indicators 2007-2015
- Other Healthcare Data Forecasts
- Key Risks To BMI's Forecast Scenario
Competitive Landscape
- Pharmaceutical Sector
- Table: Peruvian Pharmaceutical Companies That Acquired GMP Accreditation In 2006
- Foreign Industry
- Domestic Industry
- Pharmaceutical Distribution And Retail
Company Profiles
- Indigenous Manufacturer Profiles
- Farmaindustria
- Unimed
- Hersil
-

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=1715...

About Business Monitor International

Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets.  BMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports.  Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including in-depth quarterly Country Forecast Reports.  View more research from Business Monitor International at http://www.fastmr.com/catalog/publishers.aspx?pubid=1010

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

--- End ---

Click to Share

Contact Email:
***@fastmr.com Email Verified
Source:Fast Market Research
Phone:1.800.844.8156
Zip:01267
State/Province:Massachusetts - United States
Industry:Health, Medical, Research
Tags:pharmaceutical, teva, tax, Healthcare, peruvian, america, medicines, infarmasa, patented, corporaciÛn
Shortcut:prlog.org/11556423
Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Trending News...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
9K2K1K
Click to Share